Collectively, these data indicate that IDH1/2 mutations leading to an increased methylation of H3K9 and H3K79 and decreased 5-hmC may occur in a context-dependent manner in a subset of Acute Myeloid Leukemias, oligodendrogliomas and astrocytomas. The gene discussed is IDH1; the disease is acute myeloid leukemia.